Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing... Show more
AMETEK, Inc. occupies a distinctive place in the global industrial technology landscape. Organized into two operating segments — the Electronic Instruments Group (EIG), which provides advanced analytical, test, and measurement instrumentation, and the Electromechanical Group (EMG), which supplies precision motion control, thermal management, and engineered medical components — the company has spent decades assembling a portfolio of over 40 autonomous businesses that hold leading or strong secondary positions across niche markets including aerospace and defense, medical technology, power generation, and semiconductor manufacturing.
The company's competitive advantage rests on what management calls the "AMETEK Growth Model," a four-pillar framework emphasizing operational excellence, new product development, global market expansion, and disciplined strategic acquisitions. This model has produced a remarkable compounding track record: operating margins have expanded from approximately 16% in 2005 to over 26% in 2025, while free cash flow conversion consistently exceeds 110% of net income. Morningstar assigns AMETEK a wide economic moat rating, citing its collection of asset-light, high-margin businesses with significant switching costs and long product life cycles.
Compared to industrial peers such as Roper Technologies, Fortive, and Honeywell, AMETEK differentiates itself through a decentralized operating structure that preserves entrepreneurial agility within individual business units while centralizing capital allocation discipline at the corporate level. This structure enables the company to pursue bolt-on acquisitions without the integration friction that often plagues larger, more centralized conglomerates. As global manufacturing continues its long-term migration toward automation, precision sensing, and data-driven quality control, AMETEK's instrumentation portfolio is increasingly positioned as critical infrastructure rather than discretionary industrial spending.
Several high-impact catalysts stand to influence AMETEK's stock trajectory over the next 6 to 18 months.
The Indicor acquisition integration: Announced in May 2026 and valued at approximately $5 billion, the acquisition of Indicor's instrumentation portfolio represents AMETEK's largest deal to date. The transaction brings roughly $1.1 billion in annual sales across businesses that manufacture sample preparation systems, remote monitoring and control solutions, actuation technologies, and precision flow measurement instruments. Management has guided for annualized synergies of 10% to 12% of sales and expects the deal to be accretive to cash earnings in year one. With closing expected in the second half of 2026, investors will closely monitor integration milestones and whether synergy targets materialize on schedule. Historically, AMETEK has never recorded a goodwill impairment charge — a track record that lends credibility to management's integration capabilities but also sets a high bar for this transaction.
Defense spending tailwinds and aftermarket expansion: Geopolitical tensions and NATO modernization efforts continue to fuel global defense budgets. AMETEK's defense businesses — spanning ruggedized computing, advanced cooling systems for air defense platforms, power generation for unmanned aerial vehicles (UAVs), and embedded electronics — saw double-digit organic growth in late 2025. The acquisition of First Aviation Services, announced in early 2026, extends AMETEK's reach into proprietary defense aftermarket parts and MRO services, a segment characterized by high barriers to entry and long-duration revenue streams. Management has indicated that defense and aerospace should sustain high-single-digit organic growth through 2026.
Analyst sentiment and price target trajectory: The analyst community has steadily raised expectations. Truist Securities lifted its price target to $303 in July 2026, citing confidence in the acquisition-led growth strategy. Morgan Stanley, while maintaining an Equal-Weight rating, raised its target to $245. DA Davidson and RBC Capital both maintain Buy-equivalent ratings. The consensus average price target sits near $263, implying a moderate double-digit upside from mid-2026 levels. The upgrade cycle that began in late 2025 — highlighted by TD Cowen's shift from Hold to Buy and a target raise from $180 to $230 — reflects growing conviction that AMETEK can sustain above-average earnings compounding even in a mixed macroeconomic environment.
Earnings momentum and guidance trajectory: Following record 2025 results ($7.4 billion in sales, EPS of $7.43), AMETEK entered 2026 with a record backlog of $3.58 billion. Q1 2026 results exceeded consensus, with sales of $1.93 billion and adjusted EPS of $1.97, prompting management to raise full-year EPS guidance to approximately $8.04 at the midpoint. Continued beats and raises could reinforce the stock's premium valuation multiple, while any shortfall — particularly in organic growth — would likely invite scrutiny given elevated expectations.
AMETEK's forward trajectory cannot be separated from the broader macroeconomic environment. The company operates across cyclical end markets — aerospace, process industries, semiconductors, and oil and gas — that are sensitive to capital spending cycles, interest rates, and global trade dynamics.
On the positive side, several secular trends align with AMETEK's portfolio. The reshoring of manufacturing to North America and Europe, driven by supply chain security concerns and trade policy realignment, has accelerated demand for precision measurement, automation, and quality control instrumentation — all core AMETEK competencies. The global build-out of data center infrastructure to support artificial intelligence workloads is generating incremental demand for power quality monitoring, thermal management, and backup power systems, areas where AMETEK's EIG and EMG divisions both have exposure.
However, headwinds persist. The company's Machinery segment faced margin pressure in the second half of 2025 from tariff-related cost increases, and management has acknowledged that "existing known tariffs" must be offset through pricing in 2026. While AMETEK's differentiated, mission-critical products confer meaningful pricing power — CEO David Zapico has stated that pricing "is not going backwards" — sustained inflationary pressure could test margin assumptions. Additionally, approximately 48% of AMETEK's sales originate outside the United States, exposing the company to currency volatility, regional economic slowdowns, and shifting trade policies.
Interest rates remain another variable. AMETEK's balance sheet is conservatively managed, with gross debt-to-EBITDA (earnings before interest, taxes, depreciation, and amortization) of approximately 1.0x at year-end 2025 and net debt-to-EBITDA of 0.8x. The Indicor acquisition will increase leverage to roughly 2.3x at closing, still within investment-grade territory, but higher rates raise the carrying cost of acquisition-related debt. Free cash flow generation — projected at 110% to 115% of net income in 2026 — provides a buffer, but the pace of deleveraging will be closely watched.
For investors seeking to monitor AMETEK's short-term directional signals alongside the long-term strategic themes discussed in this article, Tickeron's Trend Prediction Engine offers an AI-powered forecasting tool designed to help traders assess whether a stock, ETF, or other asset may exhibit bullish, bearish, or sideways movement over a one-week or one-month horizon. The platform aggregates predictive analytics across thousands of tradable instruments, providing users with searchable prediction categories, historical context, and alert-oriented functionality to support timely decision-making. By identifying developing trends, potential breakouts, or reversal patterns, the Trend Prediction Engine complements fundamental analysis with data-driven technical perspective. Explore the full range of predictions available on Tickeron to see how AI-driven insights could enhance your market awareness.
Looking toward the remainder of 2026 and into the next several years, AMETEK's investment narrative revolves around a handful of structural themes that could define its growth trajectory.
M&A as the primary growth engine: Acquisitions have historically contributed roughly half of AMETEK's revenue growth, and management has signaled that the pipeline remains robust. CEO Zapico has stated that the company has the financial capacity to deploy over $5 billion while maintaining an investment-grade credit rating. Following the Indicor transaction, near-term focus will shift to integration and deleveraging, but additional bolt-on deals in medical technology, ultra-precision machining, and defense aftermarket services are widely expected. The company's disciplined approach — targeting asset-light, high-margin businesses with strong intellectual property and recurring revenue characteristics — reduces but does not eliminate the risk of overpaying in a competitive market for industrial technology assets.
Digital and software evolution: While AMETEK has historically been a hardware-centric company, the value proposition of its instrumentation is increasingly tied to the software and analytics layers that interpret sensor data. The vitality index — which measures sales from products introduced within the past three years — reached 30% in Q4 2025, reflecting sustained innovation investment. As industrial customers demand integrated hardware-software solutions for predictive maintenance, quality assurance, and regulatory compliance, AMETEK may need to deepen its software capabilities, potentially through targeted acquisitions that mirror the strategic pivots made by peers such as Emerson and Roper Technologies.
Margin sustainability and cost structure: Core operating margins expanded 80 basis points in 2025 and are guided for an additional 30 basis points of expansion in 2026. Management's conservative approach to guidance has historically left room for upside, but the integration of lower-margin acquisitions — particularly FARO, which is expected to see EBITDA (earnings before interest, taxes, depreciation, and amortization) margins rise from the mid-teens to approximately 30% over time — will be a key test. The AMETEK Growth Model's emphasis on continuous operational improvement provides a playbook, but achieving synergies at the scale of the Indicor portfolio requires flawless execution.
Valuation considerations: AMETEK has historically traded at a premium to the broader industrial sector, reflecting its consistent compounding record and above-average margins. As of mid-2026, the stock trades at a forward price-to-earnings multiple that sits above its 10-year average, suggesting that a significant portion of the favorable outlook is already reflected in the share price. For the bull case to hold, the company must deliver on organic growth acceleration, seamless acquisition integration, and sustained margin expansion — all while navigating an uncertain macroeconomic landscape. Consensus analyst expectations for 2026 revenue of approximately $7.88 billion and EPS near $7.96 (as reported by Yahoo Finance) provide a benchmark against which actual results will be measured.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a manufacturer of electronic instruments and electromechanical devices
Industry IndustrialMachinery
A.I.dvisor indicates that over the last year, AME has been closely correlated with ROP. These tickers have moved in lockstep 75% of the time. This A.I.-generated data suggests there is a high statistical probability that if AME jumps, then ROP could also see price increases.
| Ticker / NAME | Correlation To AME | 1D Price Change % |
|---|---|---|
| AME | 100% | +1.71% |
| AME (4 stocks) | 76% Closely correlated | +1.54% |
| Producer Manufacturing (354 stocks) | 6% Poorly correlated | -0.36% |
The Moving Average Convergence Divergence (MACD) for AME turned positive on July 22, 2026. Looking at past instances where AME's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on July 21, 2026. You may want to consider a long position or call options on AME as a result. In of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The 10-day moving average for AME crossed bullishly above the 50-day moving average on June 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AME advanced for three days, in of 330 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 278 cases where AME Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for AME moved out of overbought territory on June 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AME declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AME broke above its upper Bollinger Band on July 23, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AME’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.061) is normal, around the industry mean (5.965). P/E Ratio (36.426) is within average values for comparable stocks, (51.726). AME's Projected Growth (PEG Ratio) (3.123) is slightly higher than the industry average of (2.048). Dividend Yield (0.005) settles around the average of (0.018) among similar stocks. P/S Ratio (7.326) is also within normal values, averaging (136.254).